We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Roller Mixer Influences Coagulation Tests

By LabMedica International staff writers
Posted on 24 Nov 2011
Immediately after blood collection, the use of a roller mixer influences the ratio of rejected samples in coagulation tests.

Coagulation test results can be influenced easily by biological, preanalytical, and analytical factors due to the peculiar sensitivity of the assay methodology and the potentially adverse clinical consequences of spurious test results.

Clinical biochemists at the Ministry of Health Istanbul Research and Training Hospital (Istanbul, Turkey) retrospectively investigated blood samples collected in centralized units of outpatient clinics for prothrombin time (PT) with 24,050 in group I and 24,500 in group II. In group I, the tubes were inverted and left standing in horizontal position for less than 90 minutes at room temperature. In group II, the tubes were left standing on roller mixer for 3-5 minutes with 30 revolutions per minute (rpm).

On arrival at the clinical biochemistry laboratory, clotted samples were rejected according to “rejection criteria” defined in the laboratory procedure. Samples were rejected if before centrifugation, the clot was visible to the naked eye by moving the blood inside the tube. Samples that yield long clotting times were routinely checked for the reaction curve indicating a clot. The ratios of rejected samples of the two groups were compared statistically with chi-square analysis. The rate of rejection decreased significantly from 0.79% in group I to 0.20% in group II, the roller mixer group.

The authors concluded that using a roller mixer improves the reliability of coagulation testing. Such standardization in preanalytical phase may be helpful in preventing laboratory errors and obtaining correct test results in coagulation tests. They suggest that robotic mechanisms sending the tubes away from the roller exactly after one minute should probably be helpful in avoiding platelet activation. The study was published online on October 7, 2011, in the International Journal of Laboratory Hematology.

Related Links:

Ministry of Health Istanbul Research and Training Hospital




Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.